Sakamoto K - Search Results

1

RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.

Kato I, Furuya M, Baba M, Kameda Y, Yasuda M, Nishimoto K, Oyama M, Yamasaki T, Ogawa O, Niino H, Nakaigawa N, Yano Y, Sakamoto K, Urata Y, Mikami K, Yamasaki S, Tanaka R, Takagi T, Kondo T, Nagashima Y. Kato I, et al. Among authors: sakamoto k. Histopathology. 2019 Aug;75(2):254-265. doi: 10.1111/his.13866. Epub 2019 Jun 25. Histopathology. 2019. PMID: 30908700 Review.

2

Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications.

Kobayashi M, Uematsu T, Tokura Y, Takei K, Sakamoto K, Narimatsu T, Nukui A, Kamai T. Kobayashi M, et al. Among authors: sakamoto k. Int Braz J Urol. 2019 Jan-Feb;45(1):169-178. doi: 10.1590/S1677-5538.IBJU.2018.0271. Int Braz J Urol. 2019. PMID: 30521176 Free PMC article.

3

Multifocal Synchronous Upper Urinary Tract Carcinosarcoma (Sarcomatoid Carcinoma) With Rhabdomyoblastic Differentiation.

Takemura K, Motoi T, Tonooka A, Funata N, Nakanishi Y, Kataoka M, Ito M, Sakamoto K, Suzuki H, Tobisu KI, Koga F. Takemura K, et al. Among authors: sakamoto k. Int J Surg Pathol. 2019 Aug;27(5):547-552. doi: 10.1177/1066896919828111. Epub 2019 Feb 15. Int J Surg Pathol. 2019. PMID: 30767589

4

Prognostic significance of the controlling nutritional status (CONUT) score in advanced urothelial carcinoma patients.

Suzuki H, Ito M, Takemura K, Nakanishi Y, Kataoka M, Sakamoto K, Tobisu KI, Koga F. Suzuki H, et al. Among authors: sakamoto k. Urol Oncol. 2020 Mar;38(3):76.e11-76.e17. doi: 10.1016/j.urolonc.2019.10.014. Epub 2019 Dec 19. Urol Oncol. 2020. PMID: 31864938

5

Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.

Fukushima H, Kataoka M, Nakanishi Y, Sakamoto K, Takemura K, Suzuki H, Ito M, Tobisu KI, Fujii Y, Koga F. Fukushima H, et al. Among authors: sakamoto k. Urol Oncol. 2018 Apr;36(4):156.e9-156.e16. doi: 10.1016/j.urolonc.2017.09.016. Epub 2017 Oct 17. Urol Oncol. 2018. PMID: 29051030

6

5-Fluorouracil-based adjuvant chemotherapy improves the clinical outcomes of patients with lymphovascular invasion of upper urinary tract cancer and low expression of dihydropyrimidine dehydrogenase.

Narimatsu T, Kambara T, Abe H, Uematsu T, Tokura Y, Suzuki I, Sakamoto K, Takei K, Nishihara D, Nakamura G, Kokubun H, Yuki H, Betsunoh H, Kamai T. Narimatsu T, et al. Among authors: sakamoto k. Oncol Lett. 2019 May;17(5):4429-4436. doi: 10.3892/ol.2019.10086. Epub 2019 Feb 28. Oncol Lett. 2019. PMID: 30944635 Free PMC article.

7

Prognostic significance of serum γ-glutamyltransferase in patients with advanced urothelial carcinoma.

Takemura K, Fukushima H, Ito M, Kataoka M, Nakanishi Y, Sakamoto K, Suzuki H, Tobisu KI, Koga F. Takemura K, et al. Among authors: sakamoto k. Urol Oncol. 2019 Feb;37(2):108-115. doi: 10.1016/j.urolonc.2018.11.002. Epub 2018 Nov 24. Urol Oncol. 2019. PMID: 30478012 Clinical Trial.

8

Who Can Avoid Biopsy of Magnetic Resonance Imaging-Negative Lobes without Compromising Significant Cancer Detection among Men with Unilateral Magnetic Resonance Imaging-Positive Lobes?

Nakanishi Y, Ito M, Kataoka M, Ikuta S, Sakamoto K, Takemura K, Suzuki H, Tobisu KI, Koga F. Nakanishi Y, et al. Among authors: sakamoto k. Urol Int. 2021;105(5-6):386-393. doi: 10.1159/000511636. Epub 2020 Nov 26. Urol Int. 2021. PMID: 33242853

9

A Case of Renal Pelvic Cancer Complicated by Horseshoe Kidney Treated with RoboSurgeon Gasless Single-Port Retroperitoneoscopic Nephroureterectomy.

Suzuki H, Takemura K, Sakamoto K, Kataoka M, Ito M, Nakanishi Y, Tobisu KI, Koga F. Suzuki H, et al. Among authors: sakamoto k. Case Rep Urol. 2018 Sep 18;2018:3231480. doi: 10.1155/2018/3231480. eCollection 2018. Case Rep Urol. 2018. PMID: 30319831 Free PMC article.

10

Spontaneous regression of multiple pulmonary metastases accompanied by normalization of serum immune markers following cytoreductive nephrectomy in a patient with clear-cell renal cell carcinoma.

Okazaki A, Kijima T, Schiller P, Ishikawa N, Fuchizawa H, Takei K, Suzuki I, Sakamoto K, Tsuzuki T, Kamai T. Okazaki A, et al. Among authors: sakamoto k. IJU Case Rep. 2020 Dec 26;4(2):95-99. doi: 10.1002/iju5.12252. eCollection 2021 Mar. IJU Case Rep. 2020. PMID: 33718815 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,781 results

Search Page